KOSDAQ - Delayed Quote KRW

ABL Bio Inc. (298380.KQ)

Compare
36,350.00
+1,050.00
+(2.97%)
At close: January 31 at 3:30:09 PM GMT+9
Currency in KRW All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
32,321,035.02
65,547,054.62
67,300,799.41
5,332,068.94
8,104,203.46
Gross Profit
32,321,035.02
65,547,054.62
67,300,799.41
5,332,068.94
8,104,203.46
Operating Expense
82,774,056.74
68,174,891.66
66,394,317.13
56,522,988.00
67,754,210.00
Operating Income
-50,453,021.72
-2,627,837.04
906,482.28
-51,190,919.06
-59,650,006.54
Net Non Operating Interest Income Expense
2,689,335.37
1,300,146.83
194,780.58
5,312,071.33
949,635.63
Pretax Income
-88,430,784.65
-2,646,663.29
3,208,631.00
-43,557,942.98
-55,605,916.02
Net Income Common Stockholders
-88,430,784.65
-2,646,663.29
3,208,631.00
-43,557,942.98
-55,605,916.02
Basic EPS
-1.84k
-55.00
67.00
-927.00
-1.21k
Diluted EPS
-1.84k
-55.00
67.00
-927.00
-1.21k
Basic Average Shares
48,166.63
48,121.15
47,890.02
46,988.07
46,069.52
Diluted Average Shares
48,166.63
48,121.15
47,890.02
46,988.07
46,069.52
Total Operating Income as Reported
-50,442,286.20
-2,617,101.13
907,999.45
-52,305,340.53
-59,647,069.18
Total Expenses
82,774,056.74
68,174,891.66
66,394,317.13
56,522,988.00
67,754,210.00
Net Income from Continuing & Discontinued Operation
-88,430,784.65
-2,646,663.29
3,208,631.00
-43,557,942.98
-55,605,916.02
Normalized Income
-89,319,758.65
-4,045,023.29
3,931,102.93
-50,215,869.98
-59,639,324.02
Interest Income
1,313,751.00
1,293,888.00
233,745.00
99,717.00
368,180.00
Interest Expense
209,658.00
2,150,649.00
1,325,978.00
41,978.00
72,850.00
Net Interest Income
2,689,335.37
1,300,146.83
194,780.58
5,312,071.33
949,635.63
EBIT
-88,221,126.65
-496,014.29
4,534,609.00
-43,515,964.98
-55,533,066.02
EBITDA
-85,778,924.42
2,093,764.55
6,859,435.00
-41,357,651.98
-53,469,139.02
Reconciled Depreciation
2,442,200.00
2,589,778.00
2,324,826.00
2,158,313.00
2,063,927.00
Net Income from Continuing Operation Net Minority Interest
-88,430,784.65
-2,646,663.29
3,208,631.00
-43,557,942.98
-55,605,916.02
Total Unusual Items Excluding Goodwill
888,974.00
1,398,360.00
-996,513.00
6,657,927.00
4,033,408.00
Total Unusual Items
888,974.00
1,398,360.00
-996,513.00
6,657,927.00
4,033,408.00
Normalized EBITDA
-86,667,898.42
695,404.55
7,855,948.00
-48,015,578.98
-57,502,547.02
Tax Rate for Calcs
--
--
0.00
--
--
Tax Effect of Unusual Items
--
--
-274,041.08
--
--
12/31/2020 - 12/19/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

310210.KQ Voronoi, Inc.
86,100.00
+7.22%
 
068270.KS Celltrion, Inc.
179,700.00
-0.28%
 
228760.KQ Genomictree Inc.
18,210.00
-5.65%
 
028300.KQ HLB Co., Ltd.
80,400.00
+1.64%
 
141080.KQ LigaChem Biosciences Inc.
126,500.00
+3.27%
 
EVLO Evelo Biosciences, Inc.
0.0005
0.00%
 
196170.KQ ALTEOGEN Inc.
371,500.00
+2.62%
 
INTS Intensity Therapeutics, Inc.
2.2100
-1.78%
 
VCNX Vaccinex, Inc.
1.2500
-3.10%
 
XNCR Xencor, Inc.
18.28
-1.19%